IL4R and cancer: In a previous study, we demonstrated the potential of micelle-forming multivalent targeting based AP1-ELP (A86) polymers, emphasizing their heightened binding activity, rapid cellular entry, and efficient processing within the interleukin-4 receptor (IL-4R)-dependent endocytic pathway across diverse cancer cell lines [44].